Found: 2
Select item for more details and to access through your institution.
Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients <12 Years of Age with Hemophilia A (SWIFTLY-HA Study).
- Published in:
- Journal of Blood Medicine, 2021, v. 12, p. 483, doi. 10.2147/JBM.S299130
- By:
- Publication type:
- Article
Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study).
- Published in:
- Journal of Blood Medicine, 2020, v. 11, p. 213, doi. 10.2147/JBM.S236789
- By:
- Publication type:
- Article